External Publications Biochip Immunoassays – Cardiac

Di Serio, F., Amodio, G., Ruggieri, E., De Sario, R., Varraso, L., Antonelli, G., and Pansini, N. Proteomic approach to the diagnosis of acute coronary syndrome: preliminary results. Clin. Chim. Acta, 2005, 357(2): 226-235.

Zaninotto, M., Mion, M.M., Novello, E., Altinier, S., Rocco, S., Cacciavillani, L., Perazzolo Marra, M., Iliceto, S., and Plebani, M. Analytical and clinical evaluation of a new heart-type fatty acid-binding protein automated assay. Clin. Chem. Lab. Med. 2006, 44(11): 1383-1385.

Mion, M.M., Novello, E., Altinier, S., Rocco, S., Zaninotto, M., and Plebani, M. Analytical and clinical performance of a fully automated cardicac multi-markers strategy based on protein biochip microarray technology. Clin. Biochem. 2007, 40(16-17): 1245- 1251.

Horácek, J.M., Tichy, M., Jebavy, L., Ulrychova, M., and Pudil, R. Glycogen phosphorylase BB as a marker of cardiac toxicity during high-dose chemotherapy followed by hematopoietic cell transplantation. Ann. Oncol. 2007, 18(12): 2041.

Ulrychová, M., Horáková, L., Tichy, M., Horácek, J.M., and Pudil, R. Use of protein biochip technology for determination of cardiac markers in patients with acute myocardial infarction diagnosis by protein biochip technology. Klin.Biochem. Metab. 2008, 16(37): No. 4. (Publication in Czech).

Horácek, J.M., Tichy, M., Jebavy, L., Pudil, R, Ulrychova, M., and Maly, J. Use of multiple biomarkers for evaluation of anthracycline-induced cardiotoxicity in patients with acute myeloid leukemia. Exp. Oncol. 2008, 30(2): 157-159.

Horácek, J.M., Tichy, M., Pudil, R, Jebavy, L., Zak, P., Ulrychova, M., Vavrova, J., Maly, J., and Palicka, V. New biomarkers of myocardial injury and assessment of cardiac toxicity during preparative regimen and hematopoietic cell transplantation in acute leukemia. Clin. Chem. Lab. Med. 2008, 46(1): 148-149.

Horácek, J.M., Tichy, M., Pudil, R., Jebavy, L., Zak, P., Ulrychova, M., Slovacek, L., and
Maly, J. Multimarker approach to evaluation of cardiac toxicity during preparative regimen and hematopoietic cell transplantation. Neoplasma. 2008, 55(6): 532-537.

Horácek, J.M., Tichy, M., Pudil, R, and Jebavy, L. Glycogen phosphorylase BB could be a new circulating biomarker for detection of anthracycline cardiotoxicity. Ann. Oncol. 2008, 19(9): 1656-1657.

Lippi, G., Schena, F., Montagnana, M., Salvagno, G.L., and Guidi, G.C. Influence of acute physical exercise on emerging muscular biomarkers. Clin.Chem.Lab. Med. 2008, 46(9): 1313-1318.